AIMS joins International Federation of Biomedical Laboratory Science


Tuesday, 31 May, 2016

The Australian Institute of Medical Scientists (AIMS) has been accepted as a member of the International Federation of Biomedical Laboratory Science (IFBLS) — a global organisation of national societies working to increase opportunities for the development of medical science laboratory professionals through education and partnership.

The news was announced by IFBLS President Tom Stowe, who said, “We are very pleased that AIMS as a leading national professional body in Australia have now committed to joining over 32 countries representing approximately 140,000 members that provide biomedical laboratory services across the globe.

“The benefits for AIMS members and Australia will include access and contribution to international policy development, global events and publications,” he said.

AIMS represents all disciplines of medical diagnostic science and the community of over 23,000 medical diagnostic professionals working throughout Australia. According to the institute’s chief executive, Edward Fraser, joining IFBLS represents an exciting step in enhancing international relations and cross-fertilisation of ideas for the benefit of members and the global biomedical science community.

“AIMS is working on options to better promote medical diagnostic science professionals and the benefits of their work throughout Australia, and can learn from the successes of other countries in this regard,” Fraser said.

“We recognise being the quiet achiever is not helping our profession and, in the absence of national government quality workforce planning data and without professional regulation, we need to leverage global support to help ensure continued excellence in the sector.”

Related News

Using your brain at work may ward off cognitive impairment

The harder your brain works at your job, the less likely you may be to have memory and thinking...

Repurposed drugs show promise in heart muscle regeneration

The FDA-approved medications, when given in combination, target two proteins that regulate the...

A pre-emptive approach to treating leukaemia relapse

The monitoring of measurable residual disease (MRD), medication and low-dose chemotherapy is...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd